Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.26
(0.23%)
USD 26.26
(0.23%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.75 USD | -47.06% |
| 2022 | -0.51 USD | 23.88% |
| 2021 | -0.67 USD | -415.38% |
| 2020 | -0.13 USD | -2069.7% |
| 2019 | 0.01 USD | -99.01% |
| 2018 | 0.67 USD | 211.67% |
| 2017 | -0.60 USD | 60.0% |
| 2016 | -1.50 USD | 9.64% |
| 2015 | -1.66 USD | -49.55% |
| 2014 | -1.11 USD | -26.14% |
| 2013 | -0.88 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.38 USD | -46.15% |
| 2024 Q2 | -0.18 USD | 52.63% |
| 2023 Q2 | -0.14 USD | 36.36% |
| 2023 Q3 | -0.13 USD | 7.14% |
| 2023 FY | - USD | -47.06% |
| 2023 Q4 | -0.26 USD | -100.0% |
| 2023 Q1 | -0.22 USD | -683.55% |
| 2022 Q3 | -0.24 USD | -4.35% |
| 2022 Q1 | -0.09 USD | 68.04% |
| 2022 Q4 | 0.04 USD | 115.71% |
| 2022 FY | - USD | 23.88% |
| 2022 Q2 | -0.23 USD | -156.98% |
| 2021 Q4 | -0.28 USD | 9.68% |
| 2021 Q2 | -0.09 USD | -1216.87% |
| 2021 FY | - USD | -415.38% |
| 2021 Q1 | 0.01 USD | -77.13% |
| 2021 Q3 | -0.31 USD | -234.41% |
| 2020 Q2 | -0.01 USD | 98.16% |
| 2020 Q4 | 0.04 USD | -88.66% |
| 2020 FY | - USD | -2069.7% |
| 2020 Q1 | -0.50 USD | -600.0% |
| 2020 Q3 | 0.32 USD | 3578.26% |
| 2019 Q3 | -0.45 USD | -377.2% |
| 2019 Q4 | 0.10 USD | 122.22% |
| 2019 Q1 | 0.43 USD | -24.56% |
| 2019 Q2 | -0.09 USD | -121.93% |
| 2019 FY | - USD | -99.01% |
| 2018 Q1 | -0.17 USD | -21.43% |
| 2018 Q4 | 0.57 USD | 575.0% |
| 2018 FY | - USD | 211.67% |
| 2018 Q2 | 0.11 USD | 164.71% |
| 2018 Q3 | -0.12 USD | -209.09% |
| 2017 Q3 | -0.28 USD | -566.67% |
| 2017 Q2 | 0.06 USD | 123.08% |
| 2017 Q1 | -0.26 USD | 40.91% |
| 2017 FY | - USD | 60.0% |
| 2017 Q4 | -0.14 USD | 50.0% |
| 2016 Q2 | -0.35 USD | 18.6% |
| 2016 FY | - USD | 9.64% |
| 2016 Q1 | -0.43 USD | 18.87% |
| 2016 Q4 | -0.44 USD | -51.72% |
| 2016 Q3 | -0.29 USD | 17.14% |
| 2015 Q2 | -0.39 USD | -18.18% |
| 2015 Q1 | -0.33 USD | -10.0% |
| 2015 Q4 | -0.53 USD | -29.27% |
| 2015 FY | - USD | -49.55% |
| 2015 Q3 | -0.41 USD | -5.13% |
| 2014 Q4 | -0.30 USD | -11.11% |
| 2014 Q1 | -0.26 USD | -23.81% |
| 2014 FY | - USD | -26.14% |
| 2014 Q2 | -0.28 USD | -7.69% |
| 2014 Q3 | -0.27 USD | 3.57% |
| 2013 Q3 | -0.23 USD | 8.0% |
| 2013 Q1 | -0.19 USD | 0.0% |
| 2013 Q2 | -0.25 USD | -31.58% |
| 2013 Q4 | -0.21 USD | 8.7% |
| 2013 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -52.60 USD | 98.574% |
| BIMI International Medical Inc. | -8.40 USD | 91.071% |
| China Jo-Jo Drugstores, Inc. | -2.93 USD | 74.403% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -0.75 USD | -0.0% |
| Leafly Holdings, Inc. | -4.74 USD | 84.177% |
| Leafly Holdings, Inc. | -4.74 USD | 84.177% |
| LifeMD, Inc. | -0.70 USD | -7.143% |
| LifeMD, Inc. | -0.70 USD | -7.143% |
| TRxADE HEALTH, Inc. | -23.35 USD | 96.788% |
| PetMed Express, Inc. | -0.37 USD | -102.703% |
| Walgreens Boots Alliance, Inc. | -10.01 USD | 92.507% |